Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar OklaBoston (< 20) Submitted: 11/4/2011 2:45:13 PM : Outperform Start Price: $33.56 SLXP Score: +33.58

I don't pay much attention to analyst upgrades usually, but this got one recently and already had a PEG ratio of only 0.58, so the added publicity could be going where it will actually help investors.

Featured Broker Partners


Advertisement